GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verona Pharma PLC (GREY:VNAPF) » Definitions » E10

Verona Pharma (Verona Pharma) E10 : $0.00 (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Verona Pharma E10?

Note: As E10 is a main component used to calculate Shiller PE Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation sectione below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Verona Pharma's adjusted earnings per share data for the three months ended in Mar. 2024 was $0.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.00 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 13.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Verona Pharma was 13.10% per year. The lowest was 13.10% per year. And the median was 13.10% per year.

As of today (2024-05-24), Verona Pharma's current stock price is $0.76. Verona Pharma's E10 for the quarter that ended in Mar. 2024 was $0.00. Verona Pharma's Shiller PE Ratio of today is .


Verona Pharma E10 Historical Data

The historical data trend for Verona Pharma's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verona Pharma E10 Chart

Verona Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.56 - - -

Verona Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Verona Pharma's E10

For the Biotechnology subindustry, Verona Pharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Verona Pharma's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Verona Pharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Verona Pharma's Shiller PE Ratio falls into.



Verona Pharma E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Verona Pharma's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0/131.6000*131.6000
=0.000

Current CPI (Mar. 2024) = 131.6000.

Verona Pharma Quarterly Data

per share eps CPI Adj_EPS
201206 -0.175 95.600 -0.241
201212 -0.235 97.300 -0.318
201306 -0.155 98.000 -0.208
201312 -0.215 99.200 -0.285
201406 -0.095 99.800 -0.125
201412 -0.065 99.900 -0.086
201506 -0.185 100.100 -0.243
201512 -0.185 100.400 -0.242
201606 -0.053 101.000 -0.069
201609 -0.077 101.500 -0.100
201612 -0.013 102.200 -0.017
201703 -0.046 102.700 -0.059
201706 -0.047 103.500 -0.060
201709 -0.117 104.300 -0.148
201712 -0.083 105.000 -0.104
201803 -0.203 105.100 -0.254
201806 0.008 105.900 0.010
201809 -0.029 106.600 -0.036
201812 -0.030 107.100 -0.037
201903 -0.067 107.000 -0.082
201906 -0.108 107.900 -0.132
201909 -0.118 108.400 -0.143
201912 -0.096 108.500 -0.116
202003 -0.120 108.600 -0.145
202006 -0.080 108.800 -0.097
202009 -0.058 109.200 -0.070
202012 -0.051 109.400 -0.061
202103 -0.050 109.700 -0.060
202106 -0.050 111.400 -0.059
202109 0.000 112.400 0.000
202112 0.000 114.700 0.000
202203 0.000 116.500 0.000
202206 0.000 120.500 0.000
202209 0.000 122.300 0.000
202212 0.000 125.300 0.000
202303 0.000 126.800 0.000
202306 0.000 129.400 0.000
202309 0.000 130.100 0.000
202312 0.000 130.500 0.000
202403 0.000 131.600 0.000

Add all the adjusted EPS together and divide 10 will get our e10.


Verona Pharma  (GREY:VNAPF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Verona Pharma E10 Related Terms

Thank you for viewing the detailed overview of Verona Pharma's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Verona Pharma (Verona Pharma) Business Description

Traded in Other Exchanges
Address
3 More London Riverside, London, GBR, SE1 2RE
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma. The company is engaged in pharmaceutical development.